Bone Marrow Transplant With Abatacept for Non-Malignant Diseases
Public ClinicalTrials.gov record NCT01917708. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Abatacept for Post-Transplant Immune Suppression in Children and Adolescents Receiving Allogeneic Hematopoietic Stem Cell Transplants for Non-Malignant Diseases
Study identification
- NCT ID
- NCT01917708
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- Emory University
- Other
- Enrollment
- 10 participants
Conditions and interventions
Conditions
- Chediak-Higashi Syndrome
- Chronic Granulomatous Disease
- Diamond-Blackfan Anemia
- Dyskeratosis-congenita
- Fanconi Anemia
- Glanzmann Thrombasthenia
- Hemophagocytic Lymphohistiocytosis
- Hurler Syndrome
- Leukocyte Adhesion Deficiency
- Severe Aplastic Anemia
- Severe Congenital Neutropenia
- Shwachman-Diamond Syndrome
- Sickle Cell Disease
- Thalassemia Major
- Wiskott-Aldrich Syndrome
Interventions
- Abatacept Drug
Drug
Eligibility (public fields only)
- Age range
- Up to 21 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 31, 2013
- Primary completion
- Sep 18, 2019
- Completion
- Sep 18, 2019
- Last update posted
- Dec 25, 2019
2014 – 2019
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Children's Healthcare of Atlanta | Atlanta | Georgia | 30322 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01917708, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 25, 2019 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01917708 live on ClinicalTrials.gov.